Dynamic Effects of Ketogenic Diet on Autophagy and Cell Cycle in a Mouse Model of CT26+ Colon Cancer
Junrong Yang1, Ning Zhang1*, Muhammad Akram Khan2, Qingpeng Wang1*, Zhengping Wang1*, Quiqin Liu3, Lanjie Li3, Jun Han1, Abdul Asim Farooq4, Aayesha Riaz5 and Ruiyan Zhang1
1Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, Shandong
252000, China
2Department of Veterinary Pathology, Faculty of Veterinary and Animal Sciences PMAS-Arid Agriculture University, Rawalpindi 46000, Pakistan
3Shandong Donkey Industry, Technology Collaborative Innovation Center, Liaocheng
University, Liaocheng, China
4Department of Clinical Studies, Faculty of Veterinary Sciences, Bahauddin Zakariya
University, Multan 60800, Pakistan
5Department of Parasitology and Microbiology, Faculty of Veterinary and Animal
Sciences, PMAS-Arid Agriculture University, Rawalpindi, 46000, Pakistan
Junrong Yang and Ning Zhang are co-first author.
Fig. 1.
KD induced autophagy in CT26+ colon cancer mouse model. (A) The representative expression of Beclin-1, LC3, and p62 proteins in CT26+ tumor tissues and β-actin as the internal control for normalization. Quantitative analysis of Beclin-1 (B), LC3 (C), and p62 (D) proteins. Each experiment was repeated thrice, and all the data were presented as mean ± SEM in each case. Independent-sample T-test was used when different sets of data were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
Fig. 2.
The expression of PI3K, p-Akt, Akt, p-mTOR, mTOR, p-STAT3, STAT3 and HDAC3 proteins in CT26+ colon cancer mouse model with SD and KD treatment. (A) The representative expression of PI3K, p-Akt, Akt, p-mTOR, mTOR, p-STAT3, STAT3 and HDAC3 in CT26+ tumor tissues and β-actin as the internal control for normalization. Quantitative analysis of PI3K protein (B), the ratios of p-Akt to total Akt protein (C), the ratios of p-mTOR to total mTOR protein (D), HDAC3 protein (E) and the ratios of p-STAT3 to total STAT3 protein (F). Each experiment was repeated three times, and all the data were presented as mean ± SEM in each case. Independent-sample T-test was used when different sets of data were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
Fig. 3.
HDAC3 and STAT3 regulated the expression of PI3K, p-Akt, Akt, p-mTOR, mTOR, Beclin-1, LC3 and p62 in CT26+ colon cancer cells. The viability of CT26+ cells was detected by CCK8 with RGFP966 treatment (A) and NSC74859 treatment (B). (C) The representative expression of Beclin-1, LC3 and p62 in CT26+ cells treated with RGFP966 and NSC74859, β-actin as the internal control for normalization. Quantitative analysis of Beclin-1 (D), LC3 (E) and p62 (F) proteins in RGFP966 and NSC74859 treated groups. (G) The representative expression of PI3K, p-Akt, Akt, p-mTOR, mTOR, p-STAT3, STAT3 and HDAC3 in CT26+ colon cells treated with RGFP966 and NSC74859, β-actin as the internal control for normalization. Quantitative analysis of PI3K (H), p-Akt/Akt (I), p-mTOR/mTOR (J), HDAC3 (K) and p-STAT3/STAT3 (L) in RGFP966 and NSC74859 treated groups. Each experiment was repeated three times, and all the data were presented as mean ± SEM in each case. ANOVA was used when different sets of data were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01 and ***p < 0.001 and ns: no significance.
Fig. 4.
The effect of KD on the expression of Cyclins and CDKs in CT26+ colon cancer mouse model. (A) The representative expression of CDK4, Cyclin D1, CDK2, Cyclin E, p21 and p16 proteins in tumor tissues and β-actin as the internal control for normalization. Quantitative analysis of CDK4 (B) and Cyclin D1 (C), CDK2 (D) and Cyclin E (E), p16 (F) and p21 (G) proteins. Each experiment was repeated thrice, and all the data were presented as mean ± SEM in each case. Independent-sample T-test was used when different sets of data were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
Fig. 5.
The effect of KD on the expression of JAK2 in the CT26+ colon cancer mouse model. (A) The representative expression of p-JAK2 and JAK2 protein tumor tissues and β-actin as the internal control for normalization. (B) Quantitative analysis of p-JAK2/JAK2 ratio in tumor tissues. Each experiment was repeated three times, and all the data were presented as mean ± SEM in each case. Independent-sample T-test was used when different sets of data were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
Fig. 6.
Effect of RGFP966 and NSC74859 on the cell cycle of CT26+ colon cancer cells. (A) The representative expression of CDK4, Cyclin D1, CDK2, Cyclin E, p21 and p16 in CT26+ colon cancer cells and β-actin as the internal control for normalization. Quantitative analysis of CDK4 (B), Cyclin D1 (C), CDK2 (D), Cyclin E (E), p16 (F) and p21 (G) proteins. (H) Flow cytometric analysis of CT26+ colon cancer cells treated with RGFP966 and NSC74859. Each experiment was repeated three times, and all the data were presented as mean ± SEM in each case. One-way analysis of variance (ANOVA) was used when different data sets were compared. Statistically significant differences between different groups were indicated as *p < 0.05, **p < 0.01, ***p < 0.001and ns: no significance.
Fig. 7.
Suggested mechanism of KD on autophagy and cell cycle arrest in CT26+ tumor bearing mice.